UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds
Quick Look
UnitedHealth Group (UNH) receives bullish analyst upgrades from UBS and BofA, with price targets raised to $460 and $420 respectively, driven by strong Q1 results and confidence in margin recovery.
AI-generated summary
Why It Matters
UnitedHealth Group is a healthcare and well-being company with segments including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The article discusses recent analyst price target increases and the company's performance.
UnitedHealth Group Incorporated (NYSE:UNH) is included among the 10 High Quality Stocks to Buy According to Hedge Funds.
On May 22, UBS analyst AJ Rice raised the firm’s price recommendation on UnitedHealth Group Incorporated (NYSE:UNH) to $460 from $410. He reiterated a Buy rating on the shares. The analyst said managed care organizations broadly increased guidance after stronger-than-expected Q1 results benefited from favorable respiratory trends and seasonal cost patterns. Rice also noted that improved Medicare Advantage rates, more stable ACA exchange enrollment, and modest outperformance in Medicaid have increased confidence in margin recovery. At the same time, he said the sector continues to face cost pressures tied to specialty drugs, GLP-1s, and behavioral health.
On May 13, BofA analyst Kevin Fischbeck raised the firm’s price goal on UNH to $420 from $380. He maintained a Neutral rating on the stock. According to the analyst, the tone of discussions with the company’s leadership team at the BofA Healthcare Conference was “bullish.” Fischbeck said the company appeared confident that it could return to at least the low end of its target margins across most businesses by 2028.
UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare and well-being company with operations across Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. Its UnitedHealthcare segment includes Employer & Individual, Medicare & Retirement, and Community & State businesses.
Open Questions
- Will UNH achieve its target margins by 2028?
- How will cost pressures from specialty drugs, GLP-1s, and behavioral health affect earnings?
